## HUM: Humana Inc. - XLV: Healthcare

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 5.0% in mid entry zone (3.0-6.0%), top quartile (88th pct) cross-sectional ranking. Short-term MRS_5 (3.5%) confirms momentum alignment. Momentum building (+0.9% 5-day). Outperforming sector by 7.3%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($247.09)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Federated Hermes Inc. Acquires 57,680 Shares of Humana Inc. $HUM**
- Source: MarketBeat | 20251210T093938 | Somewhat-Bullish | Relevance: 99%
-  Federated Hermes Inc. significantly increased its stake in Humana Inc. by 69.3% in the second quarter, now owning 140,956 shares valued at $34.46 million. Other hedge funds also adjusted their holdings in the insurance provider. The article details Humana's stock performance, recent earnings, upcoming dividend, and analyst ratings, which currently average a "Hold" with a target price of $296.84.

**2. Humana Inc. $HUM Stake Lifted by Investment Management Corp of Ontario**
- Source: MarketBeat | 20251211T122809 | Somewhat-Bullish | Relevance: 98%
-  Investment Management Corp of Ontario significantly increased its stake in Humana Inc. (NYSE:HUM) by 205.5% in the second quarter, now holding 10,375 shares valued at $2,536,000. Several other institutional investors also modified their holdings, with 92.38% of the stock owned by institutional investors and hedge funds. Humana reported strong quarterly earnings and revenue, and announced a quarterly dividend of $0.885 per share.

**3. Amundi Sells 7,355 Shares of Humana Inc. $HUM**
- Source: MarketBeat | 20251209T000812 | Neutral | Relevance: 98%
-  Amundi reduced its stake in Humana Inc. by 1.9%, selling 7,355 shares and retaining 387,288 shares valued at approximately $94.42 million. Despite this, institutional ownership remains high at 92.38%, with other funds increasing their positions. Analysts have a mixed view with a consensus "Hold" rating and an average target price of $296.84 for Humana.

**4. California Public Employees Retirement System Has $53.27 Million Stock Holdings in Humana Inc. $HUM**
- Source: MarketBeat | 20251210T095938 | Somewhat-Bullish | Relevance: 98%
-  The California Public Employees Retirement System increased its stake in Humana Inc. (NYSE:HUM) by 11.9% to 217,875 shares, valued at approximately $53.27 million. Other institutional investors also made significant moves, contributing to 92.38% institutional ownership. Analysts currently have a "Hold" rating on Humana with a consensus target price of $296.84.

**5. Humana Inc. $HUM Shares Bought by State Street Corp**
- Source: MarketBeat | 20251211T120909 | Somewhat-Bullish | Relevance: 98%
-  State Street Corp increased its holdings in Humana Inc. by 1.1% in the second quarter, now owning 4.47% of the company's stock worth $1.32 billion. Several other institutional investors also adjusted their stakes in Humana, with a significant boost from Bank of Nova Scotia. Analyst ratings for Humana are varied, with a consensus "Hold" rating and an average price target of $296.84, while the company recently announced a quarterly dividend of $0.885 per share.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Jefferies | $313 | $253 | +24% |
| 2025-11-25 | Barclays | $234 | $245 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Jefferies | up | Buy |
| 2025-11-25 | Barclays | main | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 5 ($0.14M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 57.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.8% (-0.3%)
- Dodge & Cox Inc.: 9.4% (-0.1%)
- JPMORGAN CHASE & CO: 8.4% (+237.0%)
- Blackrock Inc.: 8.3% (-3.0%)
- State Street Corpora: 4.5% (-0.2%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.00 indicates undervaluation relative to growth. Balance sheet: strong liquidity (2.0x). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $32.1B |
| Beta | 0.47 |
| 52W Range | $206.87 - $315.35 |
| Short Interest | 4.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.00 |
| Forward P/E | 21.1 |
| Current P/E | 15.6 |
| YoY Growth | -26.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 improving modestly (+0.9% over 5 days). Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 88th percentile. MRS_5 at 3.5% confirms short-term momentum alignment. Outperforming sector by 7.3pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (3.85), confirming momentum. RSI neutral at 60.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 5.00% (CS: 88) | Strong |
| RSI_14 | 60.0 | Neutral |
| MACD Histogram | 3.85 | Bullish |
| vs SMA20 | 1.096x | Above |
| vs SMA50 | 1.014x | Above |
| vs SMA200 | 1.030x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $266.49
- **Stop Loss:** $247.09 (7.3% risk)
- **Target:** $295.59 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 71
- **Position Value:** $18,920.79
- **Portfolio %:** 18.92%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-11 (Est: $-3.89)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.83 | $3.24 | +14.6% |
| 2025Q2 | $5.87 | $6.27 | +6.9% |
| 2025Q1 | $10.07 | $11.58 | +15.0% |
| 2024Q4 | $-2.12 | $-2.16 | -1.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*